Prescribing Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 in Advanced Chronic Kidney Disease

Swapnil Hiremath; Michaeline McGuinty; Christos Argyropoulos; K. Scott Brimble; Pierre Brown; Zain Chagla; Rebecca  Cooper; Stephanie Hoar; David Juurlink; Darin Treleaven; Michael Walsh; Angie Yeung; Peter Blake

doi:10.2215/CJN.05270522

Invited Features

You have accessRestricted Access

Prescribing Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 in Advanced Chronic Kidney Disease

Swapnil Hiremath, Michaeline McGuinty, Christos Argyropoulos, K. Scott Brimble, Pierre Brown, Zain Chagla, Rebecca Cooper, Stephanie Hoar, David Juurlink, Darin Treleaven, Michael Walsh, Angie Yeung and Peter Blake

CJASN June 2022, CJN.05270522; DOI: https://doi.org/10.2215/CJN.05270522

Swapnil Hiremath

S Hiremath, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: shiremath@toh.ca

Michaeline McGuinty

M McGuinty, Division of Infectious Disease, Department of Medicine, University of Ottawa, Ottawa, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christos Argyropoulos

C Argyropoulos, Division of Nephrology, University of New Mexico Health Sciences Center, Albuquerque, United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

K. Scott Brimble

K Brimble, Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pierre Brown

P Brown, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Zain Chagla

Z Chagla, Division of Infectious Disease, Department of Medicine, McMaster University, Hamilton, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rebecca Cooper

R Cooper, Ontario Renal Network, Ontario Health, Toronto, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stephanie Hoar

S Hoar, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David Juurlink

D Juurlink, Department of Medicine, Sunnybrook Hospital, Toronto, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Darin Treleaven

D Treleaven, Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Walsh

M Walsh, Department of Medicine, McMaster University, Hamilton, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Angie Yeung

A Yeung, Ontario Renal Network, Ontario Health, Toronto, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peter Blake

P Blake, Division of Nephrology, Department of Medicine, Western University, London, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
View PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Clinical Journal of the American Society of Nephrology

Vol. 17, Issue 6

June 2022

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

View Selected Citations (0)

Download PDF

Email Article

Thank you for your help in sharing the high-quality science in CJASN.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Prescribing Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 in Advanced Chronic Kidney Disease

Message Subject (Your Name) has sent you a message from American Society of Nephrology

Message Body (Your Name) thought you would like to see the American Society of Nephrology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Prescribing Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 in Advanced Chronic Kidney Disease

CJASN Jun 2022, CJN.05270522; DOI: 10.2215/CJN.05270522

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Request Permissions

Prescribing Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 in Advanced Chronic Kidney Disease

CJASN Jun 2022, CJN.05270522; DOI: 10.2215/CJN.05270522

Share This Article:

Tweet Widget
Facebook Like

Jump to section

Article
Info & Metrics
View PDF

Cited By...

No citing articles found.

Google Scholar

Main menu

User menu

Search

Prescribing Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 in Advanced Chronic Kidney Disease

In this issue

Citation Manager Formats

More in this TOC Section

Cited By...

Similar Articles

Related Articles

Articles

Information for Authors

About

Journal Information

More Information